Autopsy report · NCT01178047

Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease

“payments stopped by grant provider”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 1 month before it started.
• Ran for about 1 year 1 month before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

University of Zurich

Sponsor type

University, hospital or other

Conditions

Parkinson's Disease

Interventions

Rasagiline

Participants

1

Sites

2

Countries

Switzerland

Trials that died the same way

• Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
  “Grant Terminated by Sponsor” (68% match in meaning)
• Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis
  “Funding was stoppped by grantor.” (63% match in meaning)
• Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
  “Funding withdrawn due to inability to accrue” (60% match in meaning)
• Calcium Aspirin Multiple Micronutrients (CAMMS) to Reduce Preterm Birth
  “Study grant canceled by donor” (60% match in meaning)
• Use of Kudzu Extract in the Study of Its Ability to Reduce Alcohol Drinking in Treatment Seeking Alcohol Dependent Persons
  “Grant was not funded” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.